In a filing, Cara Therapeutics Inc revealed its PRESIDENT AND CEO Posner Christopher unloaded Company’s shares for reported $5192.0 on Feb 29 ’24. In the deal valued at $0.89 per share,5,834 shares were sold. As a result of this transaction, Posner Christopher now holds 180,521 shares worth roughly $0.15 million.
Then, Goncalves Joana sold 3,293 shares, generating $2,931 in total proceeds. Upon selling the shares at $0.89, the CHIEF MEDICAL OFFICER now owns 56,118 shares.
Before that, Terrillion Scott sold 3,293 shares. Cara Therapeutics Inc shares valued at $2,931 were divested by the SEC’Y; CHIEF COMPLIANCE & G.C. at a price of $0.89 per share. As a result of the transaction, Terrillion Scott now holds 91,000 shares, worth roughly $75530.0.
BofA Securities downgraded its Cara Therapeutics Inc [CARA] rating to an Underperform from a a Neutral in a research note published on March 08, 2023; the price target was decreased to $6 from $13. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “an Overweight”. JP Morgan started covering the stock on August 03, 2021. It rated CARA as “a Neutral”.
Price Performance Review of CARA
On Monday, Cara Therapeutics Inc [NASDAQ:CARA] saw its stock fall -5.60% to $0.83. Over the last five days, the stock has lost -9.29%. Cara Therapeutics Inc shares have risen nearly 11.10% since the year began. Nevertheless, the stocks have fallen -82.47% over the past one year. While a 52-week high of $4.75 was reached on 03/04/24, a 52-week low of $0.50 was recorded on 01/25/24. SMA at 50 days reached $0.7792, while 200 days put it at $1.5413. A total of 0.58 million shares were traded, compared to the trading of 0.32 million shares in the previous session.
Levels Of Support And Resistance For CARA Stock
The 24-hour chart illustrates a support level at 0.7473, which if violated will result in even more drops to 0.6692. On the upside, there is a resistance level at 0.8918. A further resistance level may holdings at 0.9582. The Relative Strength Index (RSI) on the 14-day chart is 47.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0266, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.75%. Stochastics %K at 50.18% indicates the stock is a holding.
How much short interest is there in Cara Therapeutics Inc?
A steep rise in short interest was recorded in Cara Therapeutics Inc stocks on Mar 15, 2024, growing by 0.25 million shares to a total of 2.48 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.23 million shares. There was a rise of 10.08%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 6.33% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.32.
The most recent change occurred on April 21, 2020 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $33.
